Takeda Pharmaceutical Company Limited (TAK) is in Healthcare, Drug Manufacturers - Specialty & Generic, based in Japan, listed on NYSE. Market cap 59.16B USD. 52-week range 12.99 to 19.10 USD. Trailing P/E 42.2. Data as of 2026-10-09.
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Takhzyro, Advate, Elaprase, Replagal, Vpriv, Adynovate/Adynovi, Livtencity, ADZYNMA, Gammagard Liquid/Kiovig, ...